Calidi Biotherapeutics, Inc. - Common Stock, $0.0001 par value (CLDI) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2025 to Q4 2025

Type / Class
Equity / Common Stock, $0.0001 par value
Symbol
CLDI on NYSE
Shares outstanding
7,142,857
Price per share
$0.76
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
448,323
Total reported value
$524,682
% of total 13F portfolios
0%
Share change
+237,292
Value change
+$271,225
Number of holders
27
Price from insider filings
$0.76
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Calidi Biotherapeutics, Inc. - Common Stock, $0.0001 par value (CLDI) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Gavrilov Ognian Anguelov 9.8% +25% $532,000 +$106,400 700,000 +25% Gavrilov Ognian Anguelov 09 Mar 2026
ARMISTICE CAPITAL, LLC 5% 117,368 Armistice Capital, LLC 30 Jun 2025

As of 31 Dec 2025, 27 institutional investors reported holding 448,323 shares of Calidi Biotherapeutics, Inc. - Common Stock, $0.0001 par value (CLDI). This represents 6.3% of the company’s total 7,142,857 outstanding shares.

Institutional Holders of Calidi Biotherapeutics, Inc. - Common Stock, $0.0001 par value (CLDI) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 448,323 $524,682 +$271,225 $1.17 27
2025 Q3 211,031 $320,773 +$320,773 $1.52 21